30
CARDIOVASCULAR
hamburger
Experience the OCT difference.
Request your Abbott Sales rep today.

What is OCT?

Optical Coherence Tomography (OCT) is an imaging modality that uses near-infrared light to provide high-definition images of the artery with high precision allowing to access lesion characteristics and plaque morphology for coronary artery disease. OCT provides automated, accurate measurements to help guide stent sizing, and post-stent optimization.1

OCT Interface Visual
OCT User Interface. Pre-PCI pullback.
Photo on file at Abbott.

A - Angiogram co-registration denotes location of the cross-sectional OCT image
B - Vessel Cross-Section

- Lumen Profile (Volumetric representation of lumen area)
- Longitudinal View

Introducing the Next‑Generation Imaging Software

Ultreon™ 1.0 Software

Why OCT?

Using OCT with MLD MAX workflow to guide PCI reduces ambiguities impacting decisions on morphology assessment, vessel prep strategy and stent sizing, decisions which may affect final stent expansion2, a leading predictor of adverse events.3

 

What is MLD MAX?

MLD MAX is the new standardized step-by-step OCT workflow to guide treatment decisions pre- and post-PCI.

Six letters represent six steps of the PCI goal to MAX-imize stent expansion to deliver optimal results. The first three steps, MLD, performed before PCI, designed to help inform treatment strategy, and the last three steps, MAX, performed post-PCI, to optimize stent placement. MLD MAX was developed as a part of the LightLab Clinical Initiative.

Achieving optimal expansion is proven to reduce rates of major adverse cardiac events during PCI2. Proper expansion confirmed by imaging results in safety and efficacy benefits.4

To learn more about each step, check out these short tweets.

Post-PCI OCT | Strategize

Morphology

Search for High Calcium1

Length

Select Landing Zones Based on Healthy Tissue/ EEL Visualization2

Diameter

Measure Vessle, Stent, Balloon Diameters1

Criteria: >180 degrees, and >0.5 mm thickness, and >5 mm in length

Place landing zones in healthy tissue (i.e. EEL visualization)

Note: In the absence of EEL to represent healthy tissue find the largest lumen to avoid areas of TCFA or lipid pools so as to not land your stent edge in these high-risk areas3

Use distal reference measurements to select stent diameter

Use distal reference measurement for distal balloons or proximal reference measurements for proximal balloons

Post-PCI OCT | Optimize

Medial Dissection

Address Significant Dissection2

Apposition

Address Gross Malapposition

Xpansion

Confirm Expansion3,6

Criteria:
Dissection penetrates medial layer, and is greater than 1 quadrant arc

Criteria: Malapposition indicator show's longer than 3 mm4 of significant (≥0.3 mm from wall5) apposition

Criteria:
≥80% acceptable, ≥90% expansion is optimal

1. Fujino, A. et al. A new optical coherence tomography-based calcium scoring system to predict stent under expansion. EuroIntervention, April 2018; 13(18):e2182-e2189. 2. Prati, F. et al. The CLI-OPCI II Study. JACC: Cardiovascular Imaging, 2015: Vol 8, No. 11:1297-305. 3. Kubo, T. et al. Application of Optical Coherence Tomography in Percutaneous Coronary Intervention. Circulation Journal, September 2012: Vol. 76, 2076-2083. 4. Ali, Z. et al. ILUMIEN III: Optimize PCI. Lancet 2016, 388:2618-2628. 5. Souteyrand, G. et al. PESTO French Registry. European Heart Journal, 2016:37:1208-1216. 6. Meneveau, N. et al. DOCTORS Study. Circulation, September 2016, 134:906-917.; Zhang, J. et al. The ULTIMATE Trial. Journal of the American College of Cardiology, Dec 2018: Vol 72, No 24:3126-37.; Russo, R. et al. The AVID Trial. Circ Cardiovasc Intervent, April 2009; 2:113-123.; De Jaegere, P. et al. MUSIC Study. European Heart Journal, February 1998:19,1214-1223.

References

  1. Reyes, M. The next innovation in PCI is not a stent. The value of OCT. CathLab Digest. Oct 6, 2019. Volume 27, Issue 10.
  2. Räber L, et al. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J. 2018;39(35):3281-3300.
  3. Bezerra, H. et al: Analysis of changes in decision-making process during OCT-guided PCI -Insights from the LightLab Initiative. EuroPCR2020 Presentation.
  4. Zhang J, et al. Intravascular ultrasound versus angiography-guided drug-eluting stent implantation: the ULTIMATE trial. J Am Coll Cardiol. 2018;72(24):3126-3137.
Request a Rep

MAT-2105101 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.